Integrichain Blog

Blog

Contracts & Pricing Nick Iaconi Olivia Nweze Victoria Nolan
November 23, 2022

Consumer Price Index, Pricing Transparency Updates, and the Impact of Digital...

5 Minute Read

Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.

Contracts & Pricing Nick Iaconi Brian Bumpus Carter Hall
October 27, 2022

Stacking Discounts for Best Price, PHS & 340B, HHS Ruling

3 Minute Read

Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.

Three Pharma regulatory consultants working at a table

Contracts & Pricing Brian Bumpus Sarah Vo Carter Hall
September 27, 2022

FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice

4 Minute Read

Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.

pharmaceutical pricing strategy reporting

Contracts & Pricing Jeff Baab
August 29, 2022

The Impact of the Inflation Reduction Act on the Pharmaceutical Industry

4 Minute Read

Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.

Contracts & Pricing Olivia Nweze Darren Schneider Michael Gorokhovsky
August 19, 2022

NDC Format Proposal, Focus on PBMs, False Claims Act

4 Minute Read

August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.

Contract Banner

Contracts & Pricing Brian Bumpus Suzaun Shahamat
July 19, 2022

Legal Review: Medicare Program, 340B, and State Price Updates

6 Minute Read

July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.

Contracts & Pricing Marta Rutherford Michael Gorokhovsky
June 27, 2022

Pharma vs. 340B

4 Minute Read

This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.

pharmaceutical pricing strategy reporting

Contracts & Pricing Jeff Baab
June 14, 2022

Top Trends in Contracting

6 Minute Read

Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.

Contracts & Pricing Darren Schneider Rupal Patel
May 22, 2022

CMS Medicaid Copay Ruling

4 Minute Read

And other industry updates including the Medi-Cal older adult expansion and profiles of new pharmacy models and 3PLs entering the market.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper